Whitehawk Therapeutics
WHWK
76 hedge funds and large institutions have $192M invested in Whitehawk Therapeutics in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 6 closing their positions.
44,200% more call options, than puts
Call options by funds: $1.33M | Put options by funds: $3K
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
12% more funds holding
Funds holding: 68 → 76 (+8)
9% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 22
8.98% less ownership
Funds ownership: 71.69% → 62.71% (-9%)
10% less capital invested
Capital invested by funds: $212M → $192M (-$20.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ABG
Ally Bridge Group
New York
|
+$6.64M |
| 2 |
AIM
Alerce Investment Management
Chicago,
Illinois
|
+$4.39M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.29M |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$845K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$767K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.54M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$4.14M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$1.44M |
| 4 |
Millennium Management
New York
|
-$1.08M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$734K |
WHWK Hedge Fund Activity: Q4 2022 in Review
76 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q4 2022, worth a combined $192M — down 9.6% from $212M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new WHWK positions and 6 closed out — a net gain of 8 holders — while 20 added to existing stakes and 22 trimmed.
The largest buyer was Ally Bridge Group, adding an estimated $6.64M. The largest seller was Point72 Asset Management, cutting an estimated $6.54M.
- 76 institutional investors held Whitehawk Therapeutics (WHWK) as of Q4 2022, up from 68 in Q3 2022.
- Funds reported $192M of Whitehawk Therapeutics stock for Q4 2022, down 9.6% quarter-over-quarter.
- 14 funds opened new Whitehawk Therapeutics positions in Q4 2022 and 6 closed out, a net change of +8 holders.
- The largest Whitehawk Therapeutics buyer in Q4 2022 was Ally Bridge Group, an estimated $6.64M added.
- The largest Whitehawk Therapeutics seller in Q4 2022 was Point72 Asset Management, an estimated $6.54M sold.
Based on aggregated 13F filings for Q4 2022.